Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pancreatic beta-cell in human Type 2 diabetes.
Marchetti P, Del Prato S, Lupi R, Del Guerra S. Marchetti P, et al. Among authors: del guerra s, del prato s. Nutr Metab Cardiovasc Dis. 2006 Mar;16 Suppl 1:S3-6. doi: 10.1016/j.numecd.2005.10.017. Epub 2006 Feb 9. Nutr Metab Cardiovasc Dis. 2006. PMID: 16530127 Review.
Beta-cell failure in type 2 diabetes mellitus.
Lencioni C, Lupi R, Del Prato S. Lencioni C, et al. Among authors: del prato s. Curr Diab Rep. 2008 Jun;8(3):179-84. doi: 10.1007/s11892-008-0031-0. Curr Diab Rep. 2008. PMID: 18625113 Review.
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Endahl LA, Francisco AM, Hollander P; NN1250-3582 (BEGIN BB T2D) Trial Investigators. Garber AJ, et al. Among authors: del prato s. Lancet. 2012 Apr 21;379(9825):1498-507. doi: 10.1016/S0140-6736(12)60205-0. Lancet. 2012. PMID: 22521072 Clinical Trial.
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo G, Leonetti F, Bonadonna RC, Del Prato S; GENFIEV Investigators. Bianchi C, et al. Among authors: del prato s. J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28. J Clin Endocrinol Metab. 2013. PMID: 23539736 Clinical Trial.
545 results